Arthritis

FDA Issues Drug Warning

Published in Blood Weekly, November 2nd, 2000

Doctors should be cautious in prescribing a novel rheumatoid arthritis treatment to patients who also have multiple sclerosis (MS), and should watch out for serious anemia in anyone who uses the drug, the manufacturer warned on October 10, 2000.

There's no proof Enbrel actually causes or worsens MS symptoms, or that it causes dangerous anemia, the U.S. Food and Drug Administration (FDA) said. But manufacturer Immunex Corp. has written 100,000 doctors and pharmacists to alert them that rare cases of both problems have been reported in Enbrel users, and thus physicians should consider precautions when treating certain patients.

Among the reports: ...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2000-11-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry